According to Zacks, “HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. “
HQY has been the subject of several other research reports. J P Morgan Chase & Co started coverage on shares of HealthEquity in a report on Friday, October 28th. They issued an overweight rating and a $43.00 price target for the company. Chardan Capital reaffirmed a buy rating on shares of HealthEquity in a report on Monday. Finally, KeyCorp started coverage on shares of HealthEquity in a report on Monday, January 23rd. They set an overweight rating and a $60.00 target price for the company. One investment analyst has rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the company. The company currently has an average rating of Buy and an average price target of $40.20.
HealthEquity (NASDAQ:HQY) traded down 0.28% during mid-day trading on Monday, hitting $43.49. 568,724 shares of the stock were exchanged. The stock has a market capitalization of $2.58 billion, a PE ratio of 103.55 and a beta of 1.94. HealthEquity has a 52 week low of $16.90 and a 52 week high of $49.25. The company has a 50-day moving average of $45.03 and a 200-day moving average of $38.03.
HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, December 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.01. HealthEquity had a net margin of 15.19% and a return on equity of 11.08%. The firm earned $43.36 million during the quarter, compared to analysts’ expectations of $43.29 million. During the same period in the previous year, the business posted $0.08 EPS. The business’s revenue was up 41.9% compared to the same quarter last year. On average, equities analysts predict that HealthEquity will post $0.42 EPS for the current fiscal year.
“HealthEquity, Inc. (HQY) Downgraded by Zacks Investment Research to “Sell”” was originally reported by sleekmoney and is the sole property of of sleekmoney. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this piece of content can be read at http://sleekmoney.com/healthequity-inc-hqy-downgraded-by-zacks-investment-research-to-sell/1659152.html.
In other HealthEquity news, Director Manu S. Rana sold 382,352 shares of the company’s stock in a transaction dated Tuesday, December 20th. The shares were sold at an average price of $40.72, for a total value of $15,569,373.44. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Ashley Dreier sold 5,000 shares of the company’s stock in a transaction dated Monday, November 28th. The shares were sold at an average price of $43.38, for a total transaction of $216,900.00. Following the completion of the transaction, the vice president now directly owns 5,000 shares in the company, valued at approximately $216,900. The disclosure for this sale can be found here. Insiders sold 1,472,352 shares of company stock valued at $65,752,723 in the last three months. 29.00% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. O Shaughnessy Asset Management LLC bought a new position in HealthEquity during the fourth quarter worth approximately $108,000. Teacher Retirement System of Texas boosted its position in HealthEquity by 43.9% in the second quarter. Teacher Retirement System of Texas now owns 6,061 shares of the company’s stock worth $184,000 after buying an additional 1,850 shares during the last quarter. SG Americas Securities LLC bought a new position in HealthEquity during the third quarter worth approximately $220,000. Aperio Group LLC bought a new position in HealthEquity during the third quarter worth approximately $227,000. Finally, Mark Sheptoff Financial Planning LLC bought a new position in HealthEquity during the third quarter worth approximately $231,000. 89.22% of the stock is currently owned by institutional investors.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/healthequity-inc-hqy-downgraded-by-zacks-investment-research-to-sell/1659152.html
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.